Results 161 to 170 of about 5,631,615 (309)

A collaborative approach to improve neurotrauma care and data collection – the GEO-TBI registry

Brain and Spine
Dr. Tommi Kalevi Korhonen, Mr Midhun Mohan, Mr David Clark, Ms Sara Venturini, Mr Michael Martin, Mr Angelos Kolias, Mr Alexis Joannides, Peter Hutchinson   +7 more
doaj   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

In Vivo Imaging With a Low-Cost MRI Scanner and Cloud Data Processing in Low-Resource Settings. [PDF]

NMR Biomed
Guallart-Naval T, Asiimwe R, Tusiime P, Nassejje MA, Kinyera L, Robin L, Nayebare M, Santos LGC, Fernández-García M, Swistunow L, Algarín JM, Stairs J, Hansen M, Amodoi R, Webb A, Harper J, Schiff SJ, Obungoloch J, Alonso J.   +18 more
europepmc   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

After-Acquired Property and the Title Search [PDF]

, 1955

core   +1 more source

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

Molecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic, Anne Nørremølle, Lilian Bomme Ousager, Lars van Brakel Andersen, Marie Louise Mølgaard Binderup, Mads Thomassen   +5 more
wiley   +1 more source

Impact of Enhanced Infection Control Measures on Hospital-Acquired Carbapenem-Resistant <i>Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa</i>, and <i>Acinetobacter baumannii</i>. [PDF]

Infect Drug Resist
Li Z, Lao C, Wang H, Wang T, Lin G, Zhao H, Lin M, Zou Y, Liu B, Li C, Lin Y, Fan C.   +11 more
europepmc   +1 more source

Pathobiochemical mechanisms leading to acquired coagulation defects [PDF]

, 1985
Duswald, Karl-Heimo, Fritz, Hans, Jochum, Marianne, Schmid-Schönbein, H., Wurzinger, L. J., Zimmermann, R. E.   +5 more
core  

Acquired Ichthyosis [PDF]

Proceedings of the Royal Society of Medicine, 1929
openaire   +2 more sources

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

Molecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, Margareta Wilhelm, Ourania N Kostopoulou   +4 more
wiley   +1 more source